Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q4 2025 Earnings Call Transcript March 19, 2026 Taysha Gene Therapies, Inc. beats earnings expectations. Reported EPS is $-0.08711, expectations were ...
The FDA has released draft guidance that aims to clear up how drug developers can use alternative testing – but that doesn’t mean animal testing in the US is over.
A liquid injected into the heart that sets like a gel could one day prevent strokes caused by atrial fibrillation, animal ...
Morning Overview on MSN
New “intrabodies” could lead to treatments for MND and Alzheimer’s
Researchers are engineering a new class of miniature antibodies, called intrabodies, that can operate inside living cells to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results